Itch Relief in Atopic Dermatitis: Comparison of Narrowband Ultraviolet B Radiation and Cyclosporine Treatment

European recommendations. Statistical analyses were performed using Statistica 12 software (StatSoft, Tulsa, OK, USA) with appropriate tests (Mann–Whitney U test, Pearson’s χ 2 test and Wilcoxon signed-rank test). The level of significance was set at α 0.05.

[1]  A. Muraro,et al.  Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

[2]  S. Ständer,et al.  Patient-Reported Outcome Measures in Pruritus: A Systematic Review of Measurement Properties. , 2017, The Journal of investigative dermatology.

[3]  S. Ständer,et al.  Itch Assessment with Visual Analogue Scale and Numerical Rating Scale: Determination of Minimal Clinically Important Difference in Chronic Itch. , 2016, Acta dermato-venereologica.

[4]  E. Simpson,et al.  What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability study , 2015, The British journal of dermatology.

[5]  Hidetoshi Takahashi,et al.  Favorable clinical response by pre-prandial administration of low-dose ciclosporin to severe adult atopic dermatitis , 2012, The Journal of dermatological treatment.

[6]  T. Honda,et al.  Effects of cyclosporine on pruritus and serum IL-31 levels in patients with atopic dermatitis. , 2011, European journal of dermatology : EJD.

[7]  T. Holland-Letz,et al.  Medium‐dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study , 2009, The British journal of dermatology.

[8]  T. Paparrigopoulos,et al.  The diagnostic validity of the Athens Insomnia Scale. , 2003, Journal of psychosomatic research.

[9]  H. Kerl,et al.  Narrowband UV-B vs medium-dose UV-A1 phototherapy in chronic atopic dermatitis. , 2003, Archives of dermatology.

[10]  M. Ardigó,et al.  Sequential Treatment of Severe Atopic Dermatitis with Cyclosporin A and Low-Dose Narrow-Band UVB Phototherapy , 2002, Dermatology.

[11]  A. Finlay,et al.  Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use , 1994, Clinical and experimental dermatology.

[12]  G. Rajka,et al.  Diagnostic Features of Atopic Dermatitis , 1980, Acta Dermato-Venereologica.

[13]  M. D. de Bruin‐Weller,et al.  Narrowband ultraviolet B and medium-dose ultraviolet A1 are equally effective in the treatment of moderate to severe atopic dermatitis. , 2009, Journal of the American Academy of Dermatology.

[14]  A. Remitz,et al.  Comparison of cyclosporin and UVAB phototherapy for intermittent one-year treatment of atopic dermatitis. , 2001, Acta dermato-venereologica.

[15]  A. Scheynius,et al.  Antipruritic effect of oral cyclosporin A in atopic dermatitis. , 1990, Acta dermato-venereologica.